Evidence map›Paper›PMID 39409995›Full record

ArticleCancers2024

Palliation of Gastric Outlet Obstruction in Case of Biliary Obstruction-A Retrospective, Multicenter Study: The B-GOOD Study.

Alessandro Fugazza, Marta Andreozzi, Cecilia Binda, Andrea Lisotti, Ilaria Tarantino, Juan J Vila, Carlos Robles Medranda, Arnaldo Amato, Alberto Larghi, Enrique Perez Cuadrado Robles and 14 more

Abstract read
In one paragraph

Article in Cancers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Alessandro FugazzaDivision of Gastroenterology and Digestive Endoscopy, Humanitas Research Hospital-IRCCS, 20089 Rozzano, Italy.ORCID 0000-0003-0485-4903
Marta AndreozziDivision of Gastroenterology and Digestive Endoscopy, Humanitas Research Hospital-IRCCS, 20089 Rozzano, Italy.
Cecilia BindaGastroenterology and Digestive Endoscopy Unit, Forlì-Cesena Hospitals, AUSL Romagna, 47121 Forlì, Italy.ORCID 0000-0003-1148-9684
Andrea LisottiGastroenterology Unit, Hospital of Imola, University of Bologna, 40026 Imola, Italy.ORCID 0000-0002-7724-7402
Ilaria TarantinoEndoscopy Service, Department of Diagnostic and Therapeutic Services, IRCCS-ISMETT, 90127 Palermo, Italy.
Juan J VilaEndoscopy Unit, Gastroenterology Department, Hospital Universitario de Navarra, 310000 Navarra, Spain.
Carlos Robles MedrandaEcuadorian Institute of Digestive Diseases (IECED), Guayaquil 090505, Ecuador.
Arnaldo AmatoDigestive Endoscopy and Gastroenterology Department, ASST Lecco, 23900 Lecco, Italy.ORCID 0000-0002-4397-4142
Alberto LarghiDigestive Endoscopy Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, 00136 Rome, Italy.
Enrique Perez Cuadrado RoblesGeorges Pompidou European Hospital-APHP, 75015 Paris, France.
Giovanni AragonaGastroenterology and Digestive Endoscopy Unit, Hospital of Piacenza, 29100 Piacenza, Italy.
Francesco Di MatteoDigestive Endoscopy Unit, Campus Bio-Medico, University of Rome, 00128 Rome, Italy.
Roberta BadasDigestive Endoscopy Unit, University Hospital, 09124 Cagliari, Italy.
Cesare HassanDivision of Gastroenterology and Digestive Endoscopy, Humanitas Research Hospital-IRCCS, 20089 Rozzano, Italy.
Carmelo BarberaGastroenterology and Digestive Endoscopy Unit, Nuovo Ospedale Civile S. Agostino-Estense, 41126 Baggiovara di Modena, Italy.
Benedetto MangiavillanoGastrointestinal Endoscopy Unit, Humanitas Mater Domini, 21053 Castellanza, Italy.
Stefano CrinòDigestive Endoscopy Unit, The Pancreas Institute, University Hospital of Verona, 37126 Verona, Italy.
Matteo ColomboDivision of Gastroenterology and Digestive Endoscopy, Humanitas Research Hospital-IRCCS, 20089 Rozzano, Italy.
Carlo FabbriGastroenterology and Digestive Endoscopy Unit, Forlì-Cesena Hospitals, AUSL Romagna, 47121 Forlì, Italy.ORCID 0000-0003-0670-9910
Pietro FusaroliGastroenterology Unit, Hospital of Imola, University of Bologna, 40026 Imola, Italy.ORCID 0000-0002-4397-9314
Antonio FacciorussoGastroenterology Unit, Department of Medical Sciences, University of Foggia, 71122 Foggia, Italy.ORCID 0000-0002-2107-2156
Andrea AnderloniGastroenterology and Digestive Endoscopy Unit, IRCCS Foundation Policlinico San Matteo, 27100 Pavia, Italy.ORCID 0000-0002-1021-0031
Marco SpadacciniDivision of Gastroenterology and Digestive Endoscopy, Humanitas Research Hospital-IRCCS, 20089 Rozzano, Italy.ORCID 0000-0003-3909-9012
Alessandro RepiciDivision of Gastroenterology and Digestive Endoscopy, Humanitas Research Hospital-IRCCS, 20089 Rozzano, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEUS-guided gastroenterostomy (EUS-GE) is a novel and effective procedure for the management of malignant gastric outlet obstruction (GOO) with more durable results when compared to enteral stenting (ES). However, data comparing EUS-GE to ES in patients already treated with EUS-guided choledocoduodenostomy (EUS-CDS) for distal malignant biliary obstruction (DMBO) are lacking. We aimed to compare outcomes of EUS-GE and ES for the palliation of GOO in this specific population of patients.

methodsA multicenter, retrospective analysis of patients with DMBO treated by EUS-CDS and subsequent GOO treated by EUS-GE or ES from 2016 to 2021 was conducted. Primary outcomes were overall AEs rate and dysfunction of the EUS-CDS after GOO treatment. Secondary outcomes included clinical success, technical success, procedure duration, length of hospital stay and relapse of GOO symptoms.

resultsA total of 77 consecutive patients were included in the study: 25 patients underwent EUS-GE and 52 underwent ES. AEs rate and patency outcomes of the EUS-CDS after GOO treatment were comparable between the two groups (12.5% vs. 17.3%;

conclusionEUS-GE and ES are both effective and safe for the palliation of GOO in patients already treated by EUS-CDS for DMBO with no difference in the biliary stent dysfunction rate and overall AEs. EUS-GE is associated with less recurrence of GOO symptoms.

Indexed as

distal malignant biliary obstruction (DMBO)enteral stenting (ES)EUS-guided choledocoduodenostomy (EUS-CDS)EUS-guided gastroenterostomy (EUS-GE)gastric outlet obstruction (GOO)pancreatic cancer

Identifiers

PMID39409995
PMCPMC11475973

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.